Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Erasca Clinical Team Team
CONTACT
Les Brail, Study Director, PhD
CONTACT
Lead
Erasca, Inc.
With
This is a first-in-human, Phase 1/1b, open-label, multicenter clinical study of ERAS-0015 as a monotherapy and in combination with other cancer therapies. The study will commence with dose optimization of ERAS-0015 monotherapy, followed by dose optimization of ERAS-0015 in combination with other cancer therapies.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted